Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Thursday, July 2

I S. ~Ir PO TR ES SIN rc k 4 1:-4 13

42108 The new Cobas Core Anti-HIV-1/2 EIA DAGS II: A highly sensitive assaybased entirely on correctly folded HIV antigens
Herbert Andres*; C Boeck; H. Brodeck; S. Freiburghaus; C. Hoffmann;
B. Scheibling; K. Schnell; E.R. Schoenburner; DJ. Sizmann; K. Volz;
B. T. Weinert; M. Zauke, Switzerland
42109 Screening with combined HIV ELISA (antibody plus p24 antigen)
increases the detection rate of primary HIV-infection
Francois Simon*; S. Yerly; C. Apetrei; L. Perrin, France
42110 IgG antibodies binding to CD4+T-cells are a sensitive parameter to
discriminate between HIV1-positive and HIV1-negative children
Bernd Buchholz*; M. Miller; T. Nebe; K. Ramasubbu; M. Beichert;
P. Schdfer; K.H. Niessen, Germany
42111 Screening of anti p24 monoclonal antibodies and their use in a sensitive
HIV antigen assay on Vidas
Emilio Brignoli*; N.P. Piga; G.S. Sibai; A.F. Foussadier; J.M.H. Henry;
G. V. Vernet; MJ. Jolivet, France
42112 Total IgE levels in infants born from HIV-infected mothers
Maria Jose Miguez-Burbano*; C. Hutto; G. Scott; G. Shor-Posner;
M.A. Fletcher;M.K. Baum, USA
42113 Rapid assay evaluation for the detection of antibodies Anti HIV-1/2:
Capillus HIV-1/HIV-2
Silvina Fernandez Giuliano*; M.B. Bouzas; G. Juncos; I. Zapiola; C.
Mueller; A. Miroli; G.R.M. Muchinik, Argentina
42114 A comparative study of PCR, p24 antigen and HIV-lgA for early diagnosis
of perinatal HIV-infection in Brazilian infants
Marisa M. Mussi-Pinhata*; D.T. Covas; M. Ueda; M.C. Cervi; R. Kimura;
G. Duarte; S. Kashima, Brazil
42115 HIV-1 reverse transcriptase inhibition associated antibodies that related
to disease progression of HIV-1 infection
Fumitomo Odawara; K. Sano; H. Misaki; M.H. Lee; K. Detels;
U.S. Macs Group, Japan
42116 HIV-2 and non-B subtypes of HIV-1 Group M in specimens submitted to
the New York City Dept.of Health Retrovirology Lab.from 1993-1997
Sara T. Beatrice* W.R. Oleszko; A. Punsalang; M.A. Chiasson; L.V. Torian;
CA. Schable; I.B. Weisfuse, USA
42117 The utility of Immune-Complex-Dissociated p24 antigen in the diagnosis
of HIV vertically exposed infants in Belo Horizonte, Brazil
Jorge Pinto* A.I. Ruff, R.S. Prado;J.B. Souza; M.L. Silva; N.A. Halsey;
D.B. Greco, Brazil
42118 Application of novel "detuned" HIV EIA to qualify and monitor
antiretroviral therapy trials in patients with early HIV-infection
Bhupat D. Rawal*; F.M. Hecht; J. Kahn; M.A. Chesney; R.S. Janssen;
M.P. Busch, USA
42119 The expansion of HIV safe blood supply system and changes in blood
transfusion practices in the wake of HIV/AIDS epidemic in Myanmar
Myint Zaw*; Rai Mra; HIa Htut Lwin; Khin Ohnmar San;
Dr. Edward Zan, Myanmar
42120 Incidence of HIV-infection among apparently healthy blood donors
in Saudi Arabia (1985-1997)
Iman Al-Sheikh*; S.E. Fathalla, Saudi Arabia
42121 Use of Murex HIV recombinant and anti-HIV-2 assays to distinguish

between HIV-1 and HIV-2 infections
Richard Bristow*;J. James; R.J.S. Duncan, UK

42122 Medmira rapid HIV Screen as a supplemental test for rapid confirmation
of EIA-based HIV-positive screen result
Sam Ratnam*; Carol Head; E. Oates; V. Moulton; F. Stead, Canada
42123 Alternative strategies for screening and confirmation of HIV-1 antibodies
in Honduras
Rita Isabel Meza, Honduras
42124 Evaluation of HIV-1 RNA assays for diagnosis and quantitation of
perinatal HIV in Thailand
Sodsai Tovanabutra*; V. Gulgolgarn; S. Niyomthai; K. Loryont;
K. Junsiriyotin; M. De Souza; M. Robb, Thailand
42125 False negative HIV1-PCR in thefirsttwo months of live of a child treated
with zidovudine to reduce vertical HIV1 -transmission
Bernd Buchholz*; M. Beichert; R. Seelig; L. Grtler; K. Friese;
W. Scheurlen; K.H. Niessen, Germany
42126 A new generation test associating antigen and antibodies detection
during HIV-primary infection
Monique Baccard Longere*; P. Morand; Guillot; B. Chanzy;
J.M. Seigneurin, France
42127 Herpes zoster as a predictor of HIV-infection
Ashok Agarwal*; G. Zamzaching; N. Singh Devendra; D.K. Morens, India
42128 Isolation and preliminary characterization of two HIV-2 strains
from Pune, India
Smita Kulkarni*; S.P. Tripathy; R.S. Paranjape; D.A. Gadkari; S. Mani;
D.R. Joshi; U. Patil, India
42129 An electrochemiluminescence-based immunoassay to quantify the
HIV-1 nucleocapsid protein p7
Michel P. De Baar*; K.H.M. Van Der Horn; J. Goudsmit; A. De Ronde;
F. De Wolf, The Netherlands
42130 Prevalence of HIV- 2 infection in Calcutta (India) with a special reference
to blood donors
Dhruba Neogi* T. Chakrabarti; N. Bhattacharya, India
42131 Detection and enumeration of HIV-1-producing cells by ELISPOT
(Enzyme-Linked ImmunoSpot) assay
lean-Pierre Vendrell*; P. Corne; M.F. Huguet; L. Brian; M. Segondy;
J. Reynes, France
42132 Evaluation of microplate ELISA reader for quality control of anti-HIV test
Surapol Kohreanudom, Thailand
42133 Evaluation of the introduction of low-cost HIV testing technologies
into rural hospitals in Zambia
Simon Mphuka*; B. Mazuwa; G. Muyinda; P. Plourde; A. Ronald;
K. Sichinga; D. Chama, Zambia
42134 Screening of HIV in 740 Brazilian blood donors by multi-target reverse
transcription (RT)-linked polymerase chain reaction (PCR)
Luiz Claudio Arreas*; S. Barreto; W. Lu; J.M. Andrieu, Brazil
42135 HIV RNA in oral washes of senegalese men and women
Charlotte Ndiaye Faty*; A. Gaye Fall; M.A. Faye Niang; A.M. Coll Seek;
C. Critchlow, Senegal
42136 Advanced stage of HIV-infection among newly established Bulgarian
seropositives
DanailA. Beshkov*; V. Georgieva; 5S. Raleva; R.M. Argirova, Bulgaria

192

12th World AIDS Conference Geneva